Product
Inetetamab
2 clinical trials
2 indications
Indication
HER2-positive metastatic breast cancerIndication
HER2-positive Advanced Breast CancerClinical trial
Exploratory Study of Advanced Breast Cancer in HER2 Positive Patients With Failure of Multi-line Therapy Treated by Combination of Inetetamab (Cipterbin) + PD-1 Inhibitor Combined With Utidelone.Status: Active (not recruiting), Estimated PCD: 2021-11-04
Clinical trial
Efficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in the Treatment of Advanced Breast CancerStatus: Recruiting, Estimated PCD: 2027-12-31